PF
ENTX icon

Phoenix Financial’s Entera Bio ENTX Stock Holding History

Phoenix Financial’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,400
Closed -$14K – 417
2020
Q4 		$14K Hold
12,400
– – ﹤0.01% 364
2020
Q3 		$15K Sell
12,400
-25,000
-67% -$37.9K ﹤0.01% 316
2020
Q2 		$66K Sell
37,400
-31,955
-46% -$65.2K ﹤0.01% 305
2020
Q1 		$138K Buy
+69,355
New +$192K 0.01% 295

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Phoenix Financial's ENTX Position: Q1 2021 in Review

Phoenix Financial sold out of Entera Bio (ENTX) in Q1 2021, closing a stake of 12,400 shares — an estimated $14K sold.

Phoenix Financial first reported a position in ENTX in Q1 2020 and held it in 4 quarters. The position peaked at $138K in Q1 2020. 8 funds tracked by Wall St. Rank hold ENTX as of Q1 2021.

  • Phoenix Financial reported no remaining Entera Bio position as of Q1 2021 after selling out during the quarter.
  • Phoenix Financial sold 12,400 Entera Bio shares in Q1 2021, an estimated $14K.
  • Phoenix Financial first reported a position in Entera Bio in Q1 2020 and held it in 4 quarters.
  • Phoenix Financial's Entera Bio position peaked at $138K in Q1 2020.
  • 8 funds tracked by Wall St. Rank held Entera Bio as of Q1 2021.

Based on Phoenix Financial's 13F filing for Q1 2021, filed 10 May 2021.